ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

CAVERJECT
Erectile dysfunction
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

CAVERJECT Rx

Generic Name and Formulations:
Alprostadil 10mcg, 20mcg, 40mcg; per vial; pwd for intracavernous inj after reconstitution.

Company:
Pfizer Inc.

Therapeutic Use:

Indications for CAVERJECT:

Treatment of erectile dysfunction. Adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

Adult:

Inject into the dorso-lateral aspect of the proximal third of penis, avoid visible veins; rotate inj side and site. Determine optimum dose in office. If no response, may give 2nd dose after 1hr; if partial response occurs, wait 24hrs before next dose. Vasculogenic, psychogenic, or mixed etiology: initially 2.5mcg; if partial response, may give 2nd dose of 5mcg; may increase in increments of 5–10mcg until desired response. If no response to 1st dose, may give 2nd dose of 7.5mcg within 1hr; may increase in increments of 5–10mcg until desired response. Neurogenic etiology: initially 1.25mcg; may give 2nd dose of 2.5mcg, and 3rd dose of 5mcg; may increase in increments of 5mcg until desired response. Usual max: 60mcg and 3 inj/week; allow at least 24hrs between doses. Reduce dose if erection lasts over 1hr. Adjunct in diagnosis: see full labeling.

Children:

Not recommended; see Contraindications.

Pharmacological Class:

Prostaglandin.

Contraindications:

Predisposition to priapism. Anatomical penile deformation. Penile implants. Patients for whom sexual activity is inadvisable or contraindicated. Women. Children. Newborns.

Warnings/Precautions:

Evaluate and treat underlying causes prior to initiating therapy. Treat priapism immediately. Patient must not adjust dose on own. Reevaluate every 3 months. Significant corpora cavernosa venous leakage. Monitor for signs of penile fibrosis. Discontinue if penile angulation, cavernosal fibrosis, or Peyronie's disease develops.

Interactions:

Concomitant vasoactive agents: not recommended. Caution with anticoagulants.

Adverse Reactions:

Priapism, prolonged erection, penile pain or fibrosis, inj site hematoma or ecchymosis, prostatic disorder, penile rash or edema, other local effects, hypertension, headache, increased risk of blood-borne diseases, others.

How Supplied:

Vials 20mcg, 40mcg—6; Caverject impulse 10mcg, 20mcg—2 (dual chamber syringe systems + supplies)

CAVERJECT

  • 40mcg vials (Qty:6)
  • appx. price $446.00
GoodRx

Sign Up for Free e-newsletters